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Abstract
Introduction: An observational study was conducted using a structured observation scheme to assess compliance with the local phlebotomy gu-
ideline, to identify necessary focus items, and to investigate whether adherence to the phlebotomy guideline improved.
Materials and methods: The questionnaire from the EFLM Working Group for the Preanalytical Phase was adapted to local procedures. A pilot stu-
dy of three months duration was conducted. Based on this, corrective actions were implemented and a follow-up study was conducted. All phlebo-
tomists at the Department of Clinical Biochemistry and Pharmacology were observed. Three blood collections by each phlebotomist were observed 
at each session conducted at the phlebotomy ward and the hospital wards, respectively. Error frequencies were calculated for the phlebotomy ward 
and the hospital wards and for the two study phases.
Results: A total of 126 blood drawings by 39 phlebotomists were observed in the pilot study, while 84 blood drawings by 34 phlebotomists were 
observed in the follow-up study. In the pilot study, the three major error items were hand hygiene (42% error), mixing of samples (22%), and order 
of draw (21%). Minor significant differences were found between the two settings. After focus on the major aspects, the follow-up study showed 
significant improvement for all three items at both settings (P < 0.01, P < 0.01, and P = 0.01, respectively).
Conclusion: Continuous quality control of the phlebotomy procedure revealed a number of items not conducted in compliance with the local phle-
botomy guideline. It supported significant improvements in the adherence to the recommended phlebotomy procedures and facilitated documen-
tation of the phlebotomy quality.
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Introduction
It was recently reported that if medical error was a 
disease, it would be ranked as the third leading 
cause of death in the United States of America (1). 
As the commonly used statistic is that 70% of 
medical decisions rely on laboratory results, re-
duction of errors related to the laboratory are cru-
cial. The ongoing vast automation of the laborato-
ries certainly helps in this matter, but preanalytical 
errors remain a challenge, and studies have re-
ported that up to 75% of laboratory errors occur in 
the preanalytical phase, where the blood sam-
pling procedure is a pivotal area (2-4). It is well-
known that errors in phlebotomy can influence di-
agnosis and also affect patient care in a harmful 
way (3,4). Recent reports on the un-harmonised 
training in European countries of the personnel 
performing phlebotomy and the lack of adher-
ence to guidelines by the Clinical and Laboratory 
Standards Institute (CLSI) and the International Or-
ganization for Standardization (ISO) is therefore 
alarming (5-8). Efforts are made to improve this, 
e.g. an expansion of the pre-examination proce-
dures section in the revised international standard 
ISO 15189:2012, where laboratories are required to 
include a number of activities, e.g. collection and 
pre-collection activities, specific instructions for 
patient preparation, and sample transportation 
(7). Furthermore, the European Federation of Clini-
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cal Chemistry and Laboratory Medicine (EFLM) 
Working Group for the Preanalytical Phase (WG-
PRE) has recommended monitoring phlebotomy 
quality regularly in order to ensure the quality of 
the blood collection procedure (8). Quality control 
of phlebotomy is however challenging because er-
rors associated with phlebotomy cover a variety of 
aspects such as patient/sample misidentification, 
prolonged use of tourniquet, inadequate patient 
preparation, low blood collection volume, and im-
peded healthcare worker safety (4). It is difficult to 
collect information on all these aspects, but this 
diversity of errors is what makes striving for an ob-
jective assessment even more necessary.
A number of quality indicators have been pro-
posed, but the phlebotomy procedure itself is not 
sufficiently covered by those. In order to assure the 
quality of blood samples drawn by trained as well 
as untrained personnel a continuous, structured 
quality control assessment of the blood sampling 
procedure is needed (9). This will not only assure 
blood sampling quality, but also enable documen-
tation of sampling quality, and last but not least 
assessment of untrained personnel will make it 
possible for the laboratory organization to ensure 
the blood sample quality for all samples arriving at 
the laboratory as requested in the ISO 15189:2012.
A continuous quality control of the blood sam-
pling procedure was introduced at our university 
hospital using a structured observation scheme as 
suggested by the EFLM WG-PRE (10). The hypoth-
eses were that i) an observational quality control 
would enable identification of some critical issues 
in the blood sampling procedure, and ii) imple-
mentation of corrective actions (education of the 
staff) would result in better adherence to the 
guidelines. The aim of our study was to assess the 
level of compliance with the local phlebotomy 
guideline, to investigate if the tool could help 
identifying necessary focus items, and finally to 
study whether continuous quality control of the 
phlebotomy procedure over time would improve 
adherence to the phlebotomy guideline.
Materials and methods
Study design
The investigation was conducted at Odense Uni-
versity Hospital, Denmark, as an observational 
study in two phases: a pilot study and a follow-up 
study.
Pilot study
All staff members performing phlebotomy at De-
partment of Clinical Biochemistry and Pharmacol-
ogy, Odense University Hospital, Denmark, were 
observed. At Odense University Hospital the vast 
majority of blood samples are drawn by profes-
sionally trained laboratory technicians, an educa-
tion that includes specialised training in phleboto-
my. Blood samplings take place at either the out-
patient phlebotomy ward or at the hospital wards, 
but are carried out by the same circulating phle-
botomist staff. Due to work rotation all phleboto-
mists were not observed the exact same number 
of times.
During a three-month period (September to No-
vember 2014) blood sampling was observed at the 
outpatient phlebotomy unit and at the hospital 
wards, respectively. Three blood collections by the 
same phlebotomist were observed at each ses-
sion, and all observations were performed by the 
same trained staff specialist (TLS, first author of this 
paper and responsible for the phlebotomy proce-
dure at the hospital) using a structured checklist.
The observation checklist for quality control of 
phlebotomy was constructed based on the 
scheme designed by the EFLM WG-PRE and ad-
justed to local procedures (10). The adjustments 
were decided by the team responsible for blood 
sampling consisting of the physician in charge of 
phlebotomy, the quality control manager and the 
person responsible for education of phlebotomist 
students. As an example, use of gloves is national-
ly not recommended, and locally, checking uten-
sils for expiry dates are performed centrally. There-
fore, these two points were removed. In observa-
tion item #7 (Figure 1), the observation was used 
to ensure that the phlebotomist used standard 
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Figure 1. The questionnaire used in the pilot study.
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blood sampling devices and not a Vacutainer® 
Safety-Lok™ Blood Collection Set, which primarily 
is for paediatric use or for the difficult obtainable 
sample. Altogether, this resulted in an observation 
scheme containing 19 observation items (Figure 
1). Observation item #2 concerning patient identi-
fication was mandatory to be correct, as it was as-
sessed as potentially severely harmful. If patient 
identification was performed incorrectly, the ob-
server intervened immediately and assured cor-
rect identification. Otherwise, this was strictly an 
observational study without interruption by the 
observer. Results were recorded as yes/no for all 
phlebotomists in each setting and later calculated 
for the two settings, respectively.
Interventions
Issues identified by the pilot study (e.g. hand hy-
giene) were submitted to educational interven-
tion, including formal lectures, discussion at staff 
meetings and supervised exercises. Based on the 
pilot study the observation scheme was optimised 
by removing four items that had all been correctly 
performed in the pilot study and altering one 
item. Removed items were observations regarding 
the test request, suitable venipuncture site, fist 
clenching, and bending of the arm. The altered 
item was to check that bleeding has actually 
ceased (according to the CLSI guideline) before 
sending the patient off, not just place adhesive or 
gauze bandage at the venipuncture site. This re-
sulted in a new observation scheme containing 15 
items (Figure 2).
Follow-up study
The follow-up study was performed during a 
three-month period (January to March 2016) by 
the same procedure as described for the pilot 
study except for the alteration that only two blood 
samplings were observed at each session (for lo-
gistic reasons).
Statistical analysis
The results of the observational study are reported 
as percentage incorrect phlebotomies per item 
out of the total number of observations, reported 
for the phlebotomy ward and the hospital wards, 
respectively.
Differences between results at the two settings 
(the phlebotomy ward and the hospital wards) 
were analysed with Fisher’s exact test. Also, chang-
es in observations between the pilot study and 
the follow-up study was analysed using Pearson’s 
Chi-Square test. A P-value < 0.05 was considered 
significant; analysis was performed using Graph-
Pad Prism 6 (La Jolla, California, USA).
Results
Pilot study
A total of 126 phlebotomies, 59 at the phlebotomy 
ward and 67 at the hospital wards, were performed 
by 39 different phlebotomists. The errors revealed 
are shown in Figure 3. At the phlebotomy ward, the 
most frequent error was performing hand hygiene 
contrary to the described procedure (item #3, 42%). 
Second-most frequent was that 24% did not follow 
the correct order of draw (item #13), followed by 
improper mixing of samples by 19% (item #15).
At the hospital wards, the most frequent error was 
also 42% performing hand hygiene erroneously 
(item #3), while the second-most frequent was the 
25% that did not mix the samples properly after 
drawing blood (item #15). Finally, 18% did not fol-
low the correct order of draw (item #13). An infre-
quent, but crucial error is the patient identification 
process, which was performed incorrectly in two 
instances at the hospital wards.
Altogether, the three most frequent errors were 
identical at the two settings. Two of them did how-
ever differ significantly between the two phlebot-
omy settings, as incorrect order of draw were 
more frequent at the phlebotomy ward (P = 0.04), 
while mixing of tubes were more frequent at the 
hospital wards (P = 0.04). No other errors differed 
significantly between settings.
Follow-up study
In the follow-up study, a total of 84 phlebotomies, 
30 at the phlebotomy ward and 54 at the hospital 
ward, were performed by 34 different phleboto-
mists. The errors revealed are shown in Figure 4.
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Figure 2. The questionnaire used in the follow-up study.
At the phlebotomy ward, the by far most frequent 
error was the new item #13, where only one out of 
thirty inspected the venipuncture site for bleeding 
before sending the patient off (Figure 4). The sec-
ond-most frequent error was that 20% did not use 
the appropriate venipuncture device (item #5), fol-
lowed by item #10, where 13% did not use the cor-
rect order of draw. At one phlebotomy session, the 
patient identification process was not performed 
correct.
At the hospital wards, the most frequent error was 
also the new item #13 with 69% not inspecting the 
venipuncture site correctly. The second-most fre-
quent was item #12, where 13% did not mix the 
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samples properly after drawing, followed by 11% 
that did not use the correct order of draw (item #10).
The error frequencies that differed significantly 
between the two phlebotomy settings (phleboto-
my ward and hospital ward) were items #13 (Was 
the venipuncture site inspected for bleeding be-
fore the patient left, P = 0.01), #12 (Were all blood 
tubes mixed immediately after sampling, P = 0.02), 
and #5 (Was an appropriate venipuncture device 
used, P = 0.03).
Differences between the pilot study and the follow-
up study
The number of phlebotomies with improper hand 
hygiene was significantly lower in the follow-up 
study, namely 10% vs. 42% (both settings) in the 
pilot study (P < 0.01). Also, lack of tube mixing im-
proved from 19% at the phlebotomy ward to 3% 
(P < 0.01) and from 25% at the hospital wards to 
13% (P = 0.01). Finally, the number of erroneous or-
der of draw declined significantly from 21% (mean 
for both settings) to 12% (P = 0.01). Unfortunately, 
the number of samplings using the improper veni-
puncture device (according to the standard oper-
ating procedure) increased significantly from 8% 
to 20% at the phlebotomy ward (P = 0.01), while 
remaining unaltered at the hospital wards.
Discussion
This observational study describes a continuously 
used phlebotomy quality control system based on 
the EFLM WG-PRE guideline (10), first in an imple-
mentation phase and later in a follow-up phase. 
The pilot study reveals a number of items in need 
of focused attention and increased staff teaching, 
while the follow-up study shows significant im-
provement for the three major issues found in the 
pilot study, namely hand hygiene, order of draw 
and mixing of samples. The quality control there-
fore seems to enable the laboratory to facilitate fo-
cus on critical issues, improve sampling quality, 
and also to ensure documentation of the sampling 
QC. We will here address the specific quality issues 
and the possible future use of a phlebotomy qual-
ity control.
In the pilot study, hand hygiene was performed er-
roneously in 42% of the phlebotomies performed 
at the phlebotomy ward as well as at the hospital 
wards, while the follow-up study showed that the 
error rate had declined significantly to 10%. In 
comparison, the EFLM WG-PRE study revealed that 
25.8% of the observed phlebotomies deviated 
from the procedure recommended by CLSI re-
garding hand hygiene (10). As the error frequency 
was the same at the phlebotomy ward and at the 
Figure 3. Results from the pilot study.
The numbers on the x-axis refer to the observation items in Fig-
ure 1. White bars: Blood sampling item conducted erroneously 
at the phlebotomy ward. Black bars: Blood sampling item con-
ducted erroneously at hospital wards.
Figure 4. Results from the follow-up study. 
The numbers on the x-axis refer to the observation items in Fig-
ure 2. White bars: Blood sampling item conducted erroneously 
at the phlebotomy ward. Black bars: Blood sampling item con-
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hospitals ward, the major problem does not seem 
to have been availability of hand sanitizer, which 
one could have suspected, but rather missing 
alertness on the issue. Hand hygiene is traditional-
ly regarded as the single most important infection 
prevention, and all control measures available 
must therefore be instituted to improve adher-
ence to the guidelines on this issue. Routine hand 
hygiene audit by direct observation has been rec-
ommended in order to identify local problems 
and improve practice (10). This is however not spe-
cifically related to blood sampling, but rather to 
health care personnel in general and nurses in 
particular, where implementation of automated 
group monitoring has been shown to improve 
hand hygiene (11). Compatible with this we found 
a significant improvement using the continuous 
observational QC described here along with a 
dedicated focus on the issue.
Another frequent error was the order of draw, 
where 21% did not follow the correct procedure in 
the pilot study (24% at the phlebotomy ward and 
18% at the hospital ward). There are no good ex-
planation for the significantly higher proportion of 
incorrect draw-order at the phlebotomy clinic 
compared to the hospital wards (P = 0.03) as one 
would expect it to be the opposite due to working 
conditions etc. However, the actual difference in 
numbers are quite low (14 vs. 12 phlebotomies), so 
it could be a coincidental finding. After the issue 
was addressed specifically at staff meetings, the 
frequency of incorrect order of draw fell to 13% at 
the phlebotomy ward and 11% at the hospital 
ward. This is a little higher than the error frequen-
cy found in the EFLM study (10), where 8.1% did 
not follow the correct order of draw, and a new 
procedure has therefore recently been introduced, 
where the order of draw is shown at the labels fol-
lowing the requisition, which makes the correct 
order more evident. The importance of a specific 
order of draw as recommended in the CLSI guide-
line H3-A6 (8) has often been questioned, and 
some studies has indicated that incorrect order of 
draw under ideal phlebotomy conditions does not 
cause contamination if a closed blood collection 
system is used (12,13). It is however evident that a 
significant frequency of sample contamination 
does occur (14,15), and as this study shows ideal 
phlebotomy conditions are not always present. It 
is therefore generally recommended to follow the 
order of draw as stated in the CLSI guideline H3-
A6, which is also the procedure at our laboratory.
The third-most frequent error was improper mix-
ing of the samples: 19% did not perform this ap-
propriately at the phlebotomy ward, while the 
number was 25% at the hospital ward. In compari-
son, the error frequency in the EFLM study for this 
item was 30.4% (10). The significant difference be-
tween the phlebotomy settings could indicate 
that the working conditions at the phlebotomy 
ward are more aligned with proper laboratory 
standards, whereas sampling at the hospital wards 
often are performed under more tumultuous con-
ditions. The blood sampling quality control offers 
a possibility to document a possible critical impact 
on the sampling procedure and the following 
analysis result. Therefore, the fact that blood sam-
pling conditions are challenging at the hospital 
wards can be presented to the right authorities us-
ing the blood sampling quality control results in 
order to obtain optimal working conditions for the 
phlebotomists. Studies have shown that specially 
for coagulation testing mixing of the sample is 
crucial (16), and a recent study showed that 24% of 
the rejected tests during a year was due to a clot-
ted specimen (17). As results of coagulation testing 
often are needed fast, improper mixing must be 
corrected and e.g. the use of an automated roller 
mixer, which can be transported to the hospital 
wards, seems to improve the reliability of coagula-
tion testing (18). In the follow-up study, the error 
frequency had declined to 3% at the phlebotomy 
ward and to 13% at the hospital wards. Again, a 
clear focus on a specific procedure needing im-
provement appears to have been prosperous, but 
still there is room for improvement at the hospital 
wards.
None of these three most frequent errors were in 
the red zone described in the EFLM study as hav-
ing the highest combination of impact and proba-
bility (10). An error in the red zone is however the 
patient identification process, which according to 
the CLSI H3-A6 is crucial, and it relies entirely on 
the phlebotomist to ensure that the phlebotomy is 
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actually performed on the individual designated 
on the request form (8). Patient identification was 
performed incorrectly in two instances in the pilot 
study and once in the follow-up study. In compari-
son, the frequency of patient identification error 
was as high as 16.1% in the EFLM study (10), being 
more frequent among outpatients than at the hos-
pital wards. Regardless, this type of error is unac-
ceptable and must be avoided at all cost. Despite 
being a crucial procedure, it is not custom to ex-
amine how patient identification is actually per-
formed on a daily basis (19). However, with a con-
tinuous blood sampling quality control, misidenti-
fication errors should be eliminated by constantly 
increasing the awareness on the issue. Recently, a 
harmonisation of the patient identification proce-
dure was suggested by the EFLM WG-PRE in order 
to prevent patient identity mix-up (20), so hope-
fully such harmonized procedures can improve 
patient safety in the future.
A new item was introduced in the follow-up study, 
namely proper inspection of the venipuncture site 
to assure that bleeding indeed had stopped. The 
study showed that this was an important issue to 
include as it was almost neglected at the phlebot-
omy ward (only correctly performed in one out of 
30 phlebotomies), and also very critical at the hos-
pital wards (an error frequency of 69%). This 
strongly emphasizes that the observation scheme 
must evolve continuously to exploit new areas, 
where focus is needed. With renewed focus on 
this small item, it will hopefully be possible to 
show improvement in the error frequency for this 
issue also.
As stated the follow-up study showed that a con-
tinued focus on critical key issues indeed did result 
in a significant improvement for the three major is-
sues found in the pilot study. It is however not 
enough to identify and deal with such issues, it is 
also necessary to maintain focus on the phleboto-
my process and the alterations to come in this piv-
otal procedure. This study was not designed to 
demonstrate the possibility of such “maintenance 
value” using a quality control system, but it is our 
strong believe that it is capable of maintaining the 
focus on the phlebotomy procedure as it is seen 
for other QC systems the laboratory use every day. 
More importantly, the quality control system will 
also be an important asset outside the laboratory: 
In the health care system, increasing fiscal de-
mands and a wish for faster turn-around times are 
inevitable, and this has increased the interest in 
having other professionals than trained phleboto-
mists to perform blood sampling. A likely future 
scenario is therefore an increased number of de-
centralised blood samplings (e.g. by doctors or 
nurses at the hospital wards). From a laboratory 
point-of-view it will be essential to ascertain the 
phlebotomy quality, which will be possible 
through a blood sampling quality control.
Our study has potential strengths and limitations. 
All observations in this study were performed by 
the same person. This could be strength in the 
study, but also could be a potential bias as future 
observations probably will involve several per-
sons. However, a larger staff will on the contrary 
potentially introduce an inter-observer bias. In or-
der to avoid this, future observers will be thor-
oughly trained to assure as uniform an observa-
tion practice as possible. The questionnaire was 
adapted to local procedures and do therefore not 
fully reflect the CLSI recommendations. The pur-
pose of the study was however not to elucidate 
the adherence to the CLSI guidelines (as in the 
EFLM study), but to see if an observational quality 
control would enable identification of some criti-
cal issues in the blood sampling procedure, and 
also to disclose if implementation of corrective ac-
tions would result in better adherence to the 
guidelines; as stated we found that both these hy-
potheses were supported by the study.
In conclusion, continuous quality control of the 
blood sampling procedure using a structured ob-
servation scheme was feasible and useful. It re-
vealed a number of items that were not conduct-
ed compliant with the phlebotomy guideline. Also, 
it supported significant improvements in the ad-
herence to the recommended phlebotomy proce-
dures and facilitated documentation of the phle-
botomy quality.
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